Current knowledge and tomorrows challenges of breast, ovarian and prostate cancer genetics

Journal of Internal Medicine

Volumn 271, Issue 4, 2012, Pages 318-320

  Hall, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Genetics; Ovarian cancer; Prostate cancer

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; BRCA1 PROTEIN; BRCA2 PROTEIN;

ALLELE; BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; EDITORIAL; FUNCTIONAL GENOMICS; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE TRAIT LOCUS MAPPING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; FEMALE; HUMANS; MALE; OVARIAN NEOPLASMS; PERIODICALS AS TOPIC; PROSTATIC NEOPLASMS;

EID: 84858822253     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2012.02527.x     Document Type: Editorial

References (9)

1. Antoniou AC, Spurdle AB, Sinilnikova OM et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008; 82: 937-48.
2. Gayther SA, Song H, Ramus SJ et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007; 67: 3027-35.
3. Easton DF, Pooley KA, Dunning AM et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007; 447: 1087-93.
4. Howell A, Astley S, Warwick J et al. Prevention of breast cancer in the context of a national breast screening programme. J Intern Med 2012; 271: 321-30.
5. Barnes DR, Antoniou AC. Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers. J Intern Med 2012; 271: 321-43.
6. Turner AR, Karim Kader A, Xu J. Utility of Genome-Wide Association Study findings: prostate cancer as a translational research paradigm. J Intern Med 2012; 271: 344-52.
7. Goh CL, Schumacher FR, Easton D et al. Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med 2012; 271: 535-65.
8. Bolton KL, Ganda C, Berchuck A, Pharaoh PDP, Gayther SA. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC). J Intern Med 2012; 271: 366-78.
9. Knight JC. Resolving the variable genome and epigenome in human disease. J Intern Med 2012; 271: 379-91.